CoQ10 (Ubiquinol)
Statins deplete CoQ10 by 40-50%. The repletion protocol and the evidence behind it.
Evidence highlight
Atorvastatin 40mg reduces plasma CoQ10 by 40-50% within 30 days. Randomized trials show CoQ10 supplementation (100-300mg/day) significantly reduces statin-associated muscle pain scores.
Therapeutic dosing
Ubiquinol (reduced CoQ10)
100-300mg/day with fat-containing meal
Preferred form for patients over 40 or with poor conversion; better absorbed
Ubiquinone (oxidized CoQ10)
100-400mg/day with fat-containing meal
Standard form; adequate for most patients under 40 with good mitochondrial function
Statin depletion repletion
100-200mg ubiquinol/day minimum
Higher doses (200-300mg) for significant myopathy symptoms
Drug interactions
Warfarin — CoQ10 may reduce warfarin efficacy (structural similarity to vitamin K2); monitor INR when starting or stopping
Statins — statins deplete CoQ10 by inhibiting the same mevalonate pathway; this is the therapeutic indication, not a harmful interaction
Beta blockers — some beta blockers may reduce CoQ10 levels; supplementation may be warranted
Chemotherapy agents (doxorubicin) — CoQ10 may be cardioprotective; discuss with oncologist
Contraindications
No absolute contraindications at standard doses
Use with caution in patients on anticoagulants (monitor INR)
Labs to monitor
Mechanism of action
CoQ10 (ubiquinone) functions as an electron carrier in the mitochondrial electron transport chain (Complex I-III) and as a lipid-soluble antioxidant. Statins inhibit HMG-CoA reductase, which is upstream of both cholesterol and CoQ10 synthesis — the depletion is mechanistically unavoidable with statin use. Ubiquinol is the active, reduced form that directly participates in cellular energy production.
Clinical note
The ubiquinol vs ubiquinone distinction matters more in older patients. Conversion of ubiquinone to the active ubiquinol form declines with age and with mitochondrial dysfunction — the patients who most need CoQ10 are often the least able to convert it. Prescribe ubiquinol for patients over 40, those with ME/CFS or significant fatigue, and all statin users with myopathy.
Conditions commonly using CoQ10 (Ubiquinol)
Commonly combined with
Build a protocol using CoQ10 (Ubiquinol) in under 8 minutes
Describe your patient case. ClarityTx checks interactions automatically, grades the evidence, and generates a patient-ready protocol. First 2 protocols free.
Build your first protocol freeElevate Your Practice: Simplify Workflow & Strengthen Patient Care
- Create personalized, evidence-based protocols faster and smarter, freeing you to focus on what matters most: your patients.
- Save hours of research time daily by accessing thousands of research articles and peer-reviewed medical journals in one centralized database.
- Ensure safer, more effective patient outcomes with consistently updated, reliable information at your fingertips.
